Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 5, 2001, Pages 817-824

  Price, Paul A ^a   Faus, Samuel A ^a   Williamson, Matthew K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alendronate; Artery calcification; Bisphosphonates; Bone resorption; Ibandronate

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; IBANDRONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOSCLEROSIS; ARTERY CALCIFICATION; ARTERY MEDIA; ARTICLE; CALCIUM BLOOD LEVEL; CARBOXYLATION; MALE; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL;

EID: 0035036363     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.21.5.817     Document Type: Article

References (33)

1. Price PA, Faus SA, Williamson MK. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol. 1998;18:1400-1407.
2. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix Gla protein. Nature. 1997;386:78-81.
3. Price PA, Faus SA, Williamson MK. Warfarin-induced artery calcification is accelerated by growth and vitamin D. Arterioscler Thromb Vasc Biol. 2000;20:317-327.
4. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle W, Simonset WS. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 1998;12:1260-1268.
5. Fleisch H. Bisphosphonates: mechanisms of action. Endocr Rev. 1998; 19:80-100.
6. Schenk R, Merz WA, Muhlbauer R, Rusell RGG, Fleisch H. Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (C12 MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calcium Tissue Res. 1973;11:196-214.
7. Fleisch HA. Bisphosphonates: preclinical aspects and use in osteoporosis. Ann Med. 1997;29:55-62.
8. Muhlbauer RC, Bauss F, Schenk R, Janner M, Bosies E, Strein K, Fleisch H. BM 21.0955, a potent new bisphosphonate to inhibit bone resorption. J Bone Miner Res. 1991;6:1003-1010.
9. Schenk R, Eggle P, Fleisch H, Rosini S. Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat. Calcif Tissue Int. 1986;38:342-349.
10. Francis MD, Russell RGG, Fleisch H. Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo. Science. 1969;165:1264-1266.
11. Fleisch HA, Russell RGG, Bisaz S, Muhlbauer RC. The inhibitory effect of phosphonates on the formation of calcium phosphate crystals in vitro and on aortic and kidney calcification in vivo. Eur J Clin Invest. 1970; 1:12-18.
12. Rosenbaum IY, Black HE, Ferrell JF. The effects of various diphosphonates on a rat model of cardiac calciphylaxis. Calcif Tissue Res. 1977;23:151-159.
13. Potokar M, Schmidt-Dunker M. The inhibitory effect of new diphosphonic acids on aortic and kidney calcification in vivo. Atherosclerosis. 1978;30:313-320.
14. Kingma JGJ, Roy PE. Effect of ethane-1-hydroxy-1,1-diphosphonate on arterial calcinosis induced by hypervitaminosis D: a morphologic investigation. J Exp Pathol. 1990;71:145-153.
15. Antic VN, Fleisch H, Muhlbauer RC. Effect of bisphosphonates on the increase in bone resorption induced by a low calcium diet. Calcif Tissue Int. 1996;58:443-448.
16. Chen PS, Toribara TY, Warner H. Microdetermination of phosphorus. Anal Chem. 1956;28:1756-1758.
17. Barengolts EI, Berman M, Kukreja SC, Kouznetsova T, Lin C, Chomka EV. Osteoporosis and coronary atherosclerosis in asymptomatic post-menopausal women. Calcif Tissue Int. 1998;62:209-213.
18. Kitagawa S, Yamaguchi Y, Kunitomo M, Imaizumi N, Fujiwara M. Impairment of endothelium-dependent relaxation in aorta from rats with arteriosclerosis induced by excess vitamin D and a high-cholesterol diet. Jpn J Pharmacol. 1992;59:339-347.
19. Demer LL. A skeleton in the atherosclerosis closet. Circulation. 1995; 92:2029-2032.
20. Shanahan CM, Cary NRB, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME. Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation. 1999;100:2168-2176.
21. 3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation. 1998;98: 1302-1306.
22. Bergstrom JD, Bostedor RG, Masarachia PJ, Reszka AA, Rodan G. Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase. Arch Biochem Biophys. 2000;373:231-241.
23. Sato M, Grasser W, Endo N, Akins R, Simmons H, Thompson DD, Golub E, Rodan GA. Bisphosphonate action: alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest. 1991;88: 2095-2105.
24. Boukhris R, Becker K. Calcification of the aorta and osteoporosis: a roentgenographic study. JAMA. 1972;219:1307-1311.
25. Fujita T, Okamoto Y, Sakagami Y, Ota K, Ohata M. Bone changes and aortic calcification in aging inhabitants of mountain versus seacoast communities in the Kii peninsula. J Am Geriat Soc. 1984;32:124-128.
26. Frye MA, Melton LJ, Bryant SC, Fitzpatrick LA, Wahner HW, Schwartz RS, Riggs BL. Osteoporosis and calcification of the aorta. Bone Miner. 1992;19:185-194.
27. Banks LM, Lees B, Macsweeney JE, Stevenson JC. Effect of degenerative spinal and aortic calcification on bone density measurements in post-menopausal women: links between osteoporosis and cardiovascular disease? Eur J Clin Invest. 1994;24:813-817.
28. Jie KS, Bots ML, Vermeer C, Witteman JCM, Grobbee DE. Vitamin K status and bone mass in women with and without aortic atherosclerosis: a population based study. Calcif Tissue Int. 1996;59:352-356.
29. Nishizawa Y, Morii H. Osteoporosis and atherosclerosis in chronic renal failure. Osteoporos Int. 1997;7:S188-S192.
30. Uyama O, Yoshimoto Y, Yamamoto Y, Kawai A. Bone changes and carotid atherosclerosis in postmenopausal women. Stroke. 1997;28: 1730-1732.
31. Elkeles A. A comparative radiological study of calcified atheroma in males and females over 50 years of age. Lancet. 1957;2:714-715.
32. Melton LJ, Kan SH, Frye MA, Wahner HW, O'Fallon WM, Riggs BL. Epidemiology of vertebral fractures in women. Am J Epidemiol. 1989; 129:1000-1011.
33. Fleisch HA. Bisphosphonates: pharmacology and use in the treatment of tumor-induced hypercalcaemia and metastatic bone disease. Drugs. 1991; 42:919-944.